Corporate Social Responsibility Report (Chinese edition)

Overview

The report describes Shanghai Pharma's first entry into the Fortune Global 500 and continued growth in 2020, with营业收入 of 1,919.09亿元. It also highlights the group's extensive COVID-19 response, including the supply of nearly 1.9亿只 masks and other protective equipment, alongside a year-end workforce of 48,136 people.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2020
Period: 1 January 2020 – 31 December 2020
Language: Chinese
Pages
File size

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Ratings

GRI level

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services